Pongamia pinnata seed extract-mediated green synthesis of silver nanoparticle loaded nanogel for estimation of their antipsoriatic properties
- PMID: 38995363
- DOI: 10.1007/s00449-024-03058-5
Pongamia pinnata seed extract-mediated green synthesis of silver nanoparticle loaded nanogel for estimation of their antipsoriatic properties
Abstract
This research describes the eco-friendly green synthesis of silver nanoparticles employing Pongamia pinnata seed extracts loaded with nanogel formulations (AgNPs CUD NG) to improve the retention, accumulation, and the penetration of AgNPs into the epidermal layer of psoriasis. AgNPs were synthesized using the Box-Behnken design. Optimized AgNPs and AgNPs CUD NG were physico-chemically evaluated using UV-vis spectroscopy, SEM, FT-IR, PXRD, viscosity, spreadability, and retention studies. It was also functionally assessed using an imiquimod-induced rat model. The entrapment efficiency of AgNPs revealed ~ 79.35%. Physico-chemical parameters announced the formation of AgNPs via surface plasmon resonance and interaction between O-H, C = O, and amide I carbonyl group of protein extract and AgNO3. Optimized AgNPs showed spherical NPs ~ 116 nm with better physical stability and suitability for transdermal applications. AgNPs CUD NG revealed non-Newtonian, higher spreadability, and better extrudability, indicating its suitability for a transdermal route. AgNPs CUD NG enhanced the retention of AgNPs on the psoriatic skin compared to normal skin. Optimized formulations exhibit no irritation by the end of 72 h, indicating formulation safety. AgNPs CUD NG at a dose of 1 FTU showed significant recovery from psoriasis with a PASI score of ~ 0.8 compared to NG base and marketed formulations. Results indicated that seed extract-assisted AgNPs in association with CUD-based NG formulations could be a promising nanocarrier for psoriasis and other skin disorders.
Keywords: Antipsoriatic activity; Cow urine distillate; Nanogel; Seed extracts; Silver nanoparticles.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370:263–271. https://doi.org/10.1016/S0140-6736(07)61128-3 - DOI - PubMed
-
- Lynde CW, Poulin Y, Vender R et al (2014) Interleukin 17A: toward a new understanding of psoriasis pathogenesis. J Am Acad Dermatol 71:141–150. https://doi.org/10.1016/j.jaad.2013.12.036 - DOI - PubMed
-
- Pradhan M, Alexander A, Singh MR et al (2018) Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacother 107:447–463. https://doi.org/10.1016/j.biopha.2018.07.156 - DOI - PubMed
-
- Laxmi RJ, Karthikeyan R, Babu PS, Babu RVVN (2013) Formulation and evaluation of antipsoriatic gel using natural excipients. J Acute Dis 2:115–121. https://doi.org/10.1016/s2221-6189(13)60110-9 - DOI
-
- Avasatthi V, Pawar H, Dora CP et al (2016) A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation. Pharm Dev Technol 21:554–562. https://doi.org/10.3109/10837450.2015.1026605 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical